Familial Cancer

, Volume 3, Issue 3–4, pp 241–248 | Cite as

Fanconi anemia in Ashkenazi Jews

  • David I. Kutler
  • Arleen D. Auerbach


Fanconi anemia (FA) should be included among the genetic diseases that occur at high frequency in the Ashkenazi Jewish population. FA exhibits extensive genetic heterogeneity; there are currently 11 complementation groups reported, and 8 (i.e., FANCA, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG, and FANCL) genes have been isolated. While patients may be from widely diverse ethnic groups, a single mutation in complementation group FA-C, c.711+4A>T (commonly known as IVS4+4A>T prior to current nomenclature rules) is unique to FA patients of Ashkenazi Jewish ancestry, and has a carrier frequency of greater than 1/100 in this population. In addition, a mutation (c.65G>A) in FANCA (FA-A is the most common complementation group in non-Jewish patients) and the mutation c.6174delT in FANCD1/BRCA2 are also unique to the Ashkenazi Jewish population. Therefore, the study of Fanconi anemia can lend insight into the types of cancer-predisposing genetic diseases specific to the Ashkenazi.

BRCA2 cancer predisposition congenital malformation syndrome FANCA FANCC Fanconi anemia Jewish genetic disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Verlander PC, Kaporis A, Liu Q et al. Carrier frequency of the IVS4 +4A>T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995; 86: 4034–8.PubMedGoogle Scholar
  2. 2.
    Levran O, Erlich T, Magdalena N et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA.1997; 94(24): 13051–6.PubMedGoogle Scholar
  3. 3.
    Neuhausen S, Gilewski T, Norton L et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996; 13: 126–8.PubMedGoogle Scholar
  4. 4.
    Auerbach AD, Buchwald M, Joenje H. Fanconi Anemia.In Vogelstein B, Kinzler, KW (eds).The Genetic Basis of Human Cancer, 2nd edition. New York: McGraw-Hill 2002; 289–306.Google Scholar
  5. 5.
    Butturini A, Gale RP, Verlander PC et al. Hematologic abnor-malities in Fanconi anemia.An International Fanconi Anemia Registry study. Blood 1994; 84: 1650–5.PubMedGoogle Scholar
  6. 6.
    Giampietro PF, Adler-Brecher B, Verlander PC et al. The need for more accurate and timely diagnosis in Fanconi anemia.A report from the International Fanconi Anemia Registry.Pediatr 1993; 91: 1116–20.Google Scholar
  7. 7.
    Giampietro PF, Verlander PC, Davis JG et al. Diagnosis of Fanconi anemia in patients without congenital malformations: an International Fanconi Anemia Registry study. Am J Med Genet 1996; 68: 58–61.Google Scholar
  8. 8.
    Kutler DI, Singh B, Satagopan J et al. A 20 year perspective of The International Fanconi Anemia Registry (IFAR).Blood 2003; 101: 1249–56.PubMedGoogle Scholar
  9. 9.
    Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101(3): 822–6.PubMedGoogle Scholar
  10. 10.
    Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB)test. Exp Hematol 1993; 21: 731–3.PubMedGoogle Scholar
  11. 11.
    Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis.In Dracopoli NC, Haines JL, Korf BR et al.(eds): Current Protocols in Human Genetics.New York: John Wiley & Sons 2003; Supplement 37, 8.7.1–8.7.15.Google Scholar
  12. 12.
    Verlander PC, Shin HT, Auerbach AD. Haplotype analysis of polymorphic markers surrounding the Fanconi anemia gene FAC: evidence for a founder effect for the IVS4 +4A>T mutation. Am J Hum Genet 1995; 57: A174.[abstract ].Google Scholar
  13. 13.
    Joenje H, Oostra AB, Wijker M et al. Evidence for at least eight Fanconi anemia genes.Am J Hum Genet 1997; 61(4): 940–4.PubMedGoogle Scholar
  14. 14.
    Hanenberg H, Batish SD, Pollok KE et al. Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 2002; 30: 410–20.PubMedGoogle Scholar
  15. 15.
    Maatei AR, de Winter JP, Medhurst AL et al. A novel ubiquitin ligase is defficient in Fanconi anemia. Nat Genet 2003; 35: 165–70.PubMedGoogle Scholar
  16. 16.
    Levitus M, Rooimans MA, Steltenpool J et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 2003; Nov 20 [Epub ahead of print ].Google Scholar
  17. 17.
    Yamashita T, Wu N, Kupfer G et al. Clinical variability of Fanconi anemia (type C)results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 1996; 87: 4424–32.PubMedGoogle Scholar
  18. 18.
    Gillio AP, Verlander PC, Batish SD et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 1997; 90: 105–10.PubMedGoogle Scholar
  19. 19.
    D' Andrea AD, Grompe M. The Fanconi anaemia/BRCA path-way. Nat Rev Cancer 2003; 1: 23–34.Google Scholar
  20. 20.
    Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia.Nat Rev Genet 2001; 6: 446–57.Google Scholar
  21. 21.
    Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi 's anaemia by functional complementation. Nature 1992; 356: 763–7[published erratum appears in Nature 1992; 358: 434 ].PubMedGoogle Scholar
  22. 22.
    Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1: 196–8.PubMedGoogle Scholar
  23. 23.
    Savoia A, Centra M, Ianzano L et al. Characterization of the 5 ¢ region of the Fanconi anemia group C (FACC)gene. Hum Mol Genet 1995; 4: 1321–6.PubMedGoogle Scholar
  24. 24.
    Whitney MA, Saito H, Jakobs PM et al. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 1993; 4: 202–5.PubMedGoogle Scholar
  25. 25.
    Verlander PC, Lin JD, Udono MU et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54: 595–601.PubMedGoogle Scholar
  26. 26.
    Gibson RA, Morgan NV, Goldstein LH et al. Novel mutations and polymorphisms in the Fanconi anaemia group C gene. Hum Mutat 1996; 8: 140–8.PubMedGoogle Scholar
  27. 27.
    Lo Ten Foe JR, Barel MT, Thuss P et al. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant.Hum Genet 1996; 98: 522–3.PubMedGoogle Scholar
  28. 28.
    Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA.Nat Genet 1996; 14: 320–3.PubMedGoogle Scholar
  29. 29.
    Fanconi Anaemia/Breast Cancer Consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet 1996; 14: 324–8.Google Scholar
  30. 30.
    Howlett NG, Taniguchi T, Olson S et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297: 606–9.PubMedGoogle Scholar
  31. 31.
    Wagner JE, Tolar J, Levran O et al. Germline Mutations in BRCA2: Shared Genetic Susceptibility to Breast Cancer, Early Onset Leukemia and Fanconi Anemia. Blood 2004; Jan 8 [Epub ahead of print ].Google Scholar
  32. 32.
    Hirsch B, Shimamura A, Moreau L et al. Biallelic BRCA2/ FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood 2003; Dec 11 [Epub ahead of print ].Google Scholar
  33. 33.
    Offit K, Levran O, Mullaney B et al. Shared Genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia in an extended family. J Natl Cancer Inst 2003; 95: 1548–51.PubMedGoogle Scholar
  34. 34.
    Oddoux C, Struewing JP, Clayton CM et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.Nat Genet 1996; 14(2): 188–90.PubMedGoogle Scholar
  35. 35.
    National Human Genome Research Insitute (NHGRI).An open access on-line breast cancer mutation database: an international collaborative effort hosted by NHGRI.Retrieved from http: // research.nhgri.nih.gov/bic/on 18 August 2003.Google Scholar
  36. 36.
    Mazoyer S, Dunning AM, Serova O et al. A polymorphic stop codon in BRCA2. Nat Genet 1996; 14(3): 253–4.PubMedGoogle Scholar
  37. 37.
    Kauff ND, Perez-Segura P, Robson ME et al. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 2002; 39(8): 611–4.PubMedGoogle Scholar
  38. 38.
    Wajnrajch MP, Gertner JM, Huma Z et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744–54.PubMedGoogle Scholar
  39. 39.
    Wagner JE, MacMillan ML, Auerbach AD. Hematopoietic cell transplantation in the treatment of Fanconi anemia.In Forman SJ, Blume KG, Thomas ED (eds): Hematopoietic Cell Transplanta-tion, 3rd edition. Malden: Blackwell Science 2003; 1483–4.Google Scholar
  40. 40.
    Auerbach AD, Liu Q, Ghosh R et al. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia. Transfusion 1990; 30: 682–7.PubMedGoogle Scholar
  41. 41.
    Auerbach AD. Umbilical cord blood transplants for genetic disease: diagnostic and ethical issues in fetal studies. Blood Cells 1994; 20: 303–9.PubMedGoogle Scholar
  42. 42.
    Verlinsky Y, Rechitsky S, Schoolcraft W et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001; 285: 3130–3.PubMedGoogle Scholar
  43. 43.
    Grewal SS, Kahn JP, MacMillan ML et al. Successful hemato-poietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preim-plantation genetic diagnosis. Blood 2004; 103: 1147–51.PubMedGoogle Scholar
  44. 44.
    Wolf SM, Kahn JP, Wagner JE. Using preimplantation genetic diagnosis to create a stem cell donor: issues, guidelines &limits. J Law Med Ethics 2003; 31(3): 327–39.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • David I. Kutler
    • 1
  • Arleen D. Auerbach
    • 2
  1. 1.Department of OtolaryngologyNew York University Medical CenterUSA
  2. 2.Laboratory of Human Genetics and HematologyThe Rockefeller UniversityNew YorkUSA

Personalised recommendations